openPR Logo
Press release

Allergic Conjunctivitis Market to Hit USD 3.60 Billion by 2028; Proliferation of New Types of Allergens in Urban Areas to Stimulate Market Growth: Fortune Business Insights™

08-26-2021 09:36 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Allergic Conjunctivitis Market

Allergic Conjunctivitis Market

The global allergic conjunctivitis market size is projected to reach USD 3.60 billion by 2028, exhibiting a CAGR of 5.4% during the forecast period. The value of the market was estimated to be USD 2.40 billion in 2020 and is expected to touch USD 2.50 billion in 2021, as per the report by Fortune Business Insights™, titled “Allergic Conjunctivitis Market, 2021-2028”.

Increasing Research into Drug Efficacy to Boost the Market
Allergic eye diseases and conditions require the administration of medications that can provide considerable relief from the discomfort and possible pain from these conditions. As a result, a few companies and academic institutions are conducting intensive research to investigate the efficacy of novel therapeutics for ocular allergies. For example, in March 2021, a team from the Shanghai Jiaotong University, China, studied the effectiveness of an innovative delivery system of pemirolast potassium-loaded gellan gum in situ gel for allergic conjunctivitis. The study showed that the gel exhibited excellent stability and did not damage any part of the eye during delivery. In April 2021, according to a study published in the American Journal of Ophthalmology, Dextenza by Ocular Therapeutix can relieve ocular itching in patients suffering from this disease for nearly four weeks. Such studies are raising the potential of novel treatments for this form of conjunctivitis and fueling the growth of the market.

Request a Sample Copy of the Research Report:
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/allergic-conjunctivitis-market-100121

Segmentation
By drug class, this market has been trifurcated into antihistamines & mast cell stabilizers, corticosteroids, and others. The corticosteroids segment held a market share of 14.0% in 2020.
In terms of disease type, the market’s segments include mild and severe allergic conjunctivitis. Based on distribution channel, the market has been divided into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. On the basis of region, the market has been categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

COVID-19 Impact
The outbreak of the COVID-19 pandemic has not boded well for this market as strict lockdowns and apprehensions surrounding the coronavirus have led to a dramatic drop in visits to ophthalmologists by patients. Moreover, with elective procedures suspended by most healthcare facilities worldwide, treatments for mild to moderate ocular conditions have been postponed by doctors and other health professionals. Against the backdrop of these developments, the market growth slumped by -4% in 2020.

What Does the Report Offer?
The report contains a bird’s-eye view analysis of the market trends and drivers, as well as offers a piecemeal study of all individual market segments. Further, the report provides a thorough assessment of the market restraints and also incorporates detailed research into the regional dynamics and competitive landscape of the market.

Regulatory Clearances to Novel Medications to Support Market Growth
Recognizing the need for treating allergic conjunctivitis, regulatory bodies such as the US Food and Drug Administration (FDA) are actively green lighting novel therapies that can effectively tackle the condition and provide relief to patients. For example, in March 2021, Ocular Therapeutix’s DEXTENZA was accepted for review by the USFDA and if approved, the drug would carry an additional indication of treating ocular itching commonly associated with allergen-based conjunctivitis. Similarly, in January 2018, Alocril by Allergan was approved by the USFDA for treating eye itching in allergic conjunctivitis. The proven safety of the drug also allows it to be used on children as young as three. Supportive regulatory environment for ocular therapies and medications are, thus, proving highly beneficial for this market.

Quick Buy - Allergic Conjunctivitis Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/100121

Staggering Prevalence of Allergies in the US to Invigorate the North America Market
North America is poised to dominate the allergic conjunctivitis market share during the forecast period on account of the widespread prevalence of different kinds of allergies in the US. For example, according to the Asthma and Allergy Foundation of America, over 50 million Americans are afflicted by allergies annually and allergic conditions are the sixth-leading cause of chronic illnesses in the US. In 2020, the North America market size stood at USD 1.16 billion.

In Europe, on the other hand, the increasing adoption of advanced drugs and treatments for ocular diseases is anticipated to be the foremost growth determinant for the regional market. Meanwhile, in Asia Pacific, the rising incidence of eye allergies will be the prime factor driving the regional market.

Amplifying Customer Reach to be the Dominant Business Strategy
In solidifying their position in the market, key developers of allergic conjunctivitis therapeutics are implementing strategies that can expand their customer reach in a sustained manner. For this, companies are enhancing their distribution networks in various markets and streamlining production capabilities to augment their presence in global value chains.

Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/allergic-conjunctivitis-market-100121

Industry Development
February 2021: After securing approval from the FDA in 2020, Alcon announced that the Pataday Once Daily Relief Extra Strength, the company’s eye allergy solution, is now commercially available across offline and online stores in the US. The FDA clearance allowed the drug to be sold over-the-counter (OTC).
List of Key Players Covered in the Global Market
• Eton Pharmaceutical (Deer Park, U.S.)
• Sun Pharmaceutical Industries Ltd. (Mumbai, India)
• Novartis AG (Basel, Switzerland)
• Bausch & Lomb Incorporated (Laval, Canada)
• Allergan (AbbVie Inc.) (North Chicago, U.S.)
• Ocular Therapeutix, Inc. (Bedford, U.S.)
• Eyevance Pharmaceuticals LLC (Fort Worth, U.S.)
• Alcon (Geneva, Switzerland)
• Santen Pharmaceutical Co., Ltd. (Osaka, Japan)

Table of Content:
• Introduction
o Research Scope
o Market Segmentation
o Research Methodology
o Definitions and Assumptions
• Executive Summary
• Market Dynamics
o Market Drivers
o Market Restraints
o Market Opportunities
• Key Insights
o Prevalence of Allergic Conjunctivitis - By Key Countries
o Pipeline Analysis
o Key Industry Developments
o New Product Launches
o Impact of COVID-19 on the Allergic Conjunctivitis Market
o Allergy - Statistics and Facts
• Global Allergic Conjunctivitis Market Analysis, Insights and Forecast, 2017-2028
o Key Findings / Summary
o Market Analysis, Insights and Forecast – By Drug Class

Toc Continue..

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/allergic-conjunctivitis-market-100121

SECONDARY RESEARCH IS CONDUCTED TO DERIVE THE FOLLOWING INFORMATION:
• Details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies
• Details in relation to prevalence, incidence, patient numbers, distribution of patients, average price of treatment, etc.
• Number of end user facilities by region/country and average annual spending or procurement of devices by type of end user facility
• Number of procedures and average price of procedures
• Replacement rate and pricing of capital equipment
• Market dynamics in relation to the market under focus – Drivers, restraints, trends, and opportunities
• Market & technological trends, new product developments, product pipeline.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allergic Conjunctivitis Market to Hit USD 3.60 Billion by 2028; Proliferation of New Types of Allergens in Urban Areas to Stimulate Market Growth: Fortune Business Insights™ here

News-ID: 2368683 • Views: 282

More Releases from Fortune Business Insights

Immunoglobulin Market to Reach USD 18,378.0 Million by 2025; FDA Approval for AD …
Market Overview: The global immunoglobulin market size is expected to reach USD 18,378.0 million by 2025 exhibiting a CAGR of 7.0% during the forecast period. The increasing diagnosis rates owing to escalating awareness regarding the treatment of immunoglobulins will have a tremendous effect on the market during the forecast period, states Fortune Business Insights in a report, titled “Immunoglobulin Market Size, Share and Industry Analysis By Route of Administration (Intravenous (IV),
Life Science Instrumentation 2021 Global Market Research report covers a detaile …
Global Life Science Instrumentation market2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Life Science Instrumentation Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Life Science Instrumentation market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels
Hospital Acquired Infections Treatment 2021 Global Market Research report covers …
Global Hospital Acquired Infections Treatment market2020 industry research report gives Advancement strategies and plans are talked about just as assembling procedures and cost structures are likewise examined. Hospital Acquired Infections Treatment Market Report states import/send out utilization, organic market Figures, cost, value, income and gross edges. This report also studies the global Hospital Acquired Infections Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and
Anti-Inflammatory Biologics Market 2021-2026 Study & Future Prospects Including …
Anti-Inflammatory Biologics Market | 2021 Global Industry Forecast To 2026, is latest report on Global Anti-Inflammatory Biologics Industry, published by Fortune Business Insights. Report provides comprehensive information on Global Anti-Inflammatory Biologics Market and Impact of Covid-19 on Healthcare Industry. According to report Global market value of Anti-Inflammatory Biologics is to hit USD 149.80 billion value by 2027 at CAGR of 11.0%. Report segments Anti-Inflammatory Biologics Market By Drug Class (Anti-Tumor

All 5 Releases


More Releases for Allergic

Global Allergic Rhinitis Drugs Market Data Survey Report 2025
Global Allergic Rhinitis Drugs Market 2019 alongside scientific information of driving variables of industry, contemporary market patterns, sections, applications, and types, and additionally district shrewd investigation is ingrained in the Global Allergic Rhinitis Drugs Market Report. Basically the report focuses over the propensity of the Allergic Rhinitis Drugs advertise and deciphers its job in the global economy. The Allergic Rhinitis Drugs advertise report comprises a fundamentals information in regards to
Allergic Rhinitis Drugs Market Report By CMI
Introduction of new drugs is expected to drive growth of the market Manufacturers are developing a variety of drugs and nasal sprays for the treatment of allergic rhinitis. This in turn, is expected to fuel growth of the allergic rhinitis drugs market in the near future. For instance, in March 2017, the U.S. Food and Drug Administration (FDA) approved Odactra drug, manufactured by Catalent Pharma Solutions Limited, the first allergen
Allergic Rhinitis Market 2018 by Seasonal, Perennial and Non Allergic Rhinitis T …
The Allergic Rhinitis Market is segmented into types, by treatment and by test. The types of the allergic rhinitis includes seasonal, perennial and non-allergic rhinitis. On the basis of the treatment the segmentation is done into antihistamines, decongestants, eye drops, nasal sprays, immunotherapy, sublingual immunotherapy (SLIT) and home remedies. The antihistamine segment is further sub-segmented into drugs like allegra, clarinex, xyzal and zyrtec. The decongestants segment is also sub-segmented into
Global Allergic Rhinitis Market Research Report - Pipeline Review, H2 2017
"The Latest Research Report Allergic Rhinitis-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Allergic Rhinitis Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis-Pipeline Review, H2 2017, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape. Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled.
Allergic Conjunctivitis - Pipeline Review, H2 2016
MarketResearchReports.Biz presents this most up-to-date research on "Allergic Conjunctivitis - Pipeline Review, H2 2016" Description Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis Pipeline Review, H2 2016, provides an overview of the Allergic Conjunctivitis (Ophthalmology) pipeline landscape. Allergic conjunctivitis occurs when the clear layer of tissue lining the eyelids and covering the white of the eye (conjunctiva) become swollen or inflamed due to a reaction to pollen, dander, mold,
Allergic Rhinitis Market driven by the increasing incidence of allergic rhinitis
This market research report on the global allergic rhinitis market provides a comprehensive overview of the structure and the dynamics of this market. Thus, the report throws light on the factors governing the market trends in the global allergic rhinitis market. This market research report discusses the demand drivers and the various challenges facing the industry. Historical and contemporary data as included in the research study provide a strong foundation